Technical Analysis for MTZXF - Mitsubishi Tanabe Ph

Grade Last Price % Change Price Change
grade F 10.8 0.47% 0.0500
MTZXF closed up 0.47 percent on Monday, October 7, 2019, on 16 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical MTZXF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.47%
Expansion Breakdown Bearish Swing Setup 0.47%
Narrow Range Bar Range Contraction 0.47%
New 52 Week Low Weakness 0.47%
Wide Bands Range Expansion 0.47%
Gapped Down Weakness 0.47%

Older signals for MTZXF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mitsubishi Tanabe Pharma Corporation manufactures and sells pharmaceuticals in Japan, Europe, North America, other Asian countries, and internationally. The company offers drugs for autoimmune, diabetes, kidney, central nervous system, and other disease treatment; and vaccines, as well as sells generic drugs and over-the-counter (OTC) products. It offers Remicade for treatment of rheumatoid arthritis (RA), Crohn's, Bechet's, psoriasis, ankylosing spondylitis, and ulcerative colitis diseases; Simponi for the treatment of RA; Kremezin for the treatment of chronic renal failure; and Tenelia for type II diabetes mellitus. The company also provides Ceredist for the treatment of spinocerebellar degeneration; Depas, an anti-anxiety agent; Lexapro, an anti-depressant agent; Imusera for multiple sclerosis; Radicut, a cerebral neuroprotectant; Talion for the treatment of allergic disorders; Maintate for the treatment of hypertension, angina pectoris, ventricular extrasystole, chronic heart failure, and atrial fibrillation; Urso that improves hepatic, biliary, and digestive functions; and Anplag, an anti-platelet agent. In addition, it offers TETRABIK, a vaccine for diphtheria, pertussis, tetanus, and poliomyelitis; Varicella vaccine for the prevention of chicken pox; Influenza vaccine; Mearubik, a vaccine for measles and rubella; and JEBIK V for the prevention of Japanese encephalitis. Further, the company provides OTC products, including agents for the treatment of skin conditions; tonic and nutritional supplements; herbal and digestive medicines; and oral agents for allergic rhinitis and recurrent vaginal candidiasis. Additionally, it provides information about pharmaceuticals; and invests in bio-ventures. The company has collaborations with Dyadic International, Inc.; Hitachi Ltd.; and HitGen Ltd. The company was founded in 1678 and is headquartered in Osaka, Japan. The company is a subsidiary of Mitsubishi Chemical Holdings Corporation.
Medicine RTT Medical Specialties Pharmaceuticals Drugs Diabetes Pharmaceutical Industry In China Medication Disease Hypertension Multiple Sclerosis Psoriasis Rheumatoid Arthritis Influenza Vaccines Allergic Rhinitis Atrial Fibrillation Treatment Of Hypertension Angina Pectoris Chronic Heart Failure Janssen Biotech Measles Rhinitis Spondylitis Chronic Renal Failure Crohn's Japanese Encephalitis Remicade Rubella Tnf Inhibitors Varicella Allergic Disorders Chicken Pox Diphtheria Golimumab Ii Diabetes Mellitus Pertussis Poliomyelitis Prevention Of Chicken Pox Recurrent Vaginal Candidiasis Schering Plough Spinocerebellar Degeneration Tetanus Treatment Of Allergic Disorders Treatment Of Chronic Renal Failure Ulcerative Colitis Diseases Ventricular Extrasystole
Is MTZXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 24.24
52 Week Low 10.75
Average Volume 3,695
200-Day Moving Average 0.0
50-Day Moving Average 16.4319
20-Day Moving Average 12.9422
10-Day Moving Average 11.2578
Average True Range 0.4112
ADX 46.36
+DI 21.0078
-DI 74.5491
Chandelier Exit (Long, 3 ATRs ) 14.9664
Chandelier Exit (Short, 3 ATRs ) 11.9836
Upper Bollinger Band 16.6188
Lower Bollinger Band 9.2656
Percent B (%b) 0.21
BandWidth 56.815688
MACD Line -1.6679
MACD Signal Line -1.6399
MACD Histogram -0.028
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.8000
Resistance 3 (R3) 10.8000 10.8000 10.8000
Resistance 2 (R2) 10.8000 10.8000 10.8000 10.8000
Resistance 1 (R1) 10.8000 10.8000 10.8000 10.8000 10.8000
Pivot Point 10.8000 10.8000 10.8000 10.8000 10.8000
Support 1 (S1) 10.8000 10.8000 10.8000 10.8000 10.8000
Support 2 (S2) 10.8000 10.8000 10.8000 10.8000
Support 3 (S3) 10.8000 10.8000 10.8000
Support 4 (S4) 10.8000